Angewandte
Chemie
thymine catabolism.[12] Finally, we synthesized samples of the
paratoside part#9 and the unusual xyloadenosine derivative,
npar#1. By comparing the HPLC-retention times of natural
part#9 and several synthetic part#9 diastereomers, we found
that natural part#9 must be either d-paratosyl-4S-hydroxy-
pentanoic acid or l-paratosyl-4R-hydroxypentanoic acid (Fig-
ure S6). We initially assumed that part#9 and npar#1 con-
tained d-paratose, which had previously been described from
bacteria whereas l-paratose had not been found in nature.
Furthermore, d-paratose is a putative intermediate in the
biosynthesis of l-ascarylose,[11] on which all ascarosides in
nematodes are based.[4e,10,13] However, the HPLC retention
time and NMR spectra of a synthetic npar#1 diastereomer
including d-paratosyl-4S-hydroxypentanoic acid did not
match the data obtained for natural npar#1 (Figure S7a).
Therefore, we concluded that npar#1 must be based on l-
paratosyl-4R-hydroxypentanoic acid, which was confirmed by
synthesizing this diastereomer and comparing its spectro-
scopic data with those of natural npar#1 (Figure S7b,c). Using
chiral derivatization agents (Mosherꢀs acid chlorides),[14] we
further showed that part#9 is also based on l-paratose
(Figure S8). The sugar l-paratose has not previously been
found in nature; however, its occurrence in nematodes might
result from epimerization of l-ascarylose at position 2.
To exclude the possibility that the identified compounds
are bacterial metabolites, we additionally analyzed the
metabolome of the E. coli OP50 bacteria used as food for
P. pacificus. None of the identified compounds were found to
be present in the bacterial metabolome (Figure S9). Further-
more, we showed that all identified compounds are also
produced in P. pacificus cultures fed with Pseudomonas sp.
instead of E. coli as well as in axenic (bacteria-free) cul-
tures[4d,15] (Figure S10).
Next we asked whether assembly of the identified small
molecules from sugar, amino acid, lipid, and nucleoside-
derived building blocks is selective. To address this, we
carefully re-analyzed the entire P. pacificus exometabolome
by high-resolution HPLC-MS/MS, quantified the identified
compounds using synthetic standards (Table S1), and
screened for homologues or alternative combinations of the
primary metabolism-derived building blocks in our structures.
We found that pasc#9 is accompanied by trace amounts of two
homologues including six- and seven-carbon side chains,
which were also detected by NMR spectroscopy (Figure S11).
In addition, we detected a small amount of a homologue of
ubas#1 as well as a derivative of npar#1 whose MS data
indicated loss of the xylose (ubas#2 and npar#2 in Figure 2a,
Table S1). Importantly, we did not observe any non-specific or
seemingly random combinations of building blocks that
would suggest a non-enzymatic genesis of the identified
compounds.
physiologically observed (20 mm, Figure S12). In contrast,
physiological concentrations of the nucleoside derivative
npar#1 strongly induced dauer formation and appear to
account for most of the reported dauer-inducing activity in the
non-fractionated exometabolome (Figure 3a,c).[9] Addition-
ally, we observed weaker dauer induction with part#9 than
Figure 3. Regulation of mouth dimorphism and dauer induction by
synthetic samples of identified P. pacificus metabolites. All experiments
were performed in triplicate for each treatment. a,b) Compounds were
assayed at 1 mm concentration (*=p<0.01, **=p<0.001). c,d) Com-
pounds with significant activity at 1 mm (p<0.01) were subsequently
tested at a range of concentrations.
with npar#1, whereas all other compounds tested were
inactive in this assay. Testing our synthetic compounds in
the mouth dimorphism assay, we found that the dimeric
compound dasc#1, which was inactive in the dauer-formation
assay, strongly induces the eurystomatous mouth form (Fig-
ure 3b,d). In addition, weaker induction of the eurystomatous
mouth form was observed for high concentrations of pasc#9,
ascr#1, and npar#1, whereas ascr#9 and part#9 as well as the
dimeric ubas#1 were inactive at physiological concentrations
in the wild-type strain tested (Figure 3b, Table S1).
These results show that adult phenotypic plasticity and
larval development in P. pacificus are controlled by distinct
yet partially overlapping sets of signaling molecules. Whereas
mouth-form dimorphism is primarily regulated by dasc#1, the
product of highly specific ascaroside dimerization, dauer
formation is controlled by a molecule combining a paratoside
with an unusual nucleoside. Previous work showed that the
signaling molecules controlling phenotypic plasticity in
P. pacificus act upstream of evolutionarily conserved tran-
scription factors, including DAF-16/FOXO and the nuclear
hormone receptor DAF-12 (Figure 4),[18] whereby daf-12 is
required for both dauer induction and mouth-form dimor-
phism, whereas daf-16, is required for dauer induction but
dispensable for regulation of mouth-form dimorphism.[18a]
Therefore, the different subsets of small molecules regulating
dauer formation and mouth-form dimorphism appear to
target different downstream effectors. Based on the recent
We then tested synthetic samples of the identified
compounds for their activity in the P. pacificus dauer- and
mouth-form-dimorphism assays. As expected from previous
studies that showed that C. elegans exometabolome samples
are not active in the P. pacificus mouth-form dimorphism and
dauer assays,[16] we found that ascr#1, a compound abundantly
excreted by C. elegans,[4e,17] has no dauer-inducing activity in
P. pacificus, even at concentrations higher than what is
Angew. Chem. Int. Ed. 2012, 51, 12438 –12443
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim